Table 3
Coefficient of variation for midazolam clearance in paediatrics
Age
Critically ill (%) (n)
Non-critically ill (%) (n)
Preterm neonates
72–106 (118)
–
Term neonates
18–73 (231)
–
Infants
31–130 (57)
53 (5)
children
21–170 (50)
13–54 (67)
Adolescents
47–150 (6)
40–50 (22)